—
The hemophilia market has entered into an era of unprecedented growth rate with a variety of treatment options. Development of new therapeutics along with expansion in the current treatment options has presented new opportunities to the market. Hemophilia being an inherited genetic bleeding disorder causes abnormal bleeding with poor clotting. It is classified into hemophilia A, hemophilia B, hemophilia C, and hemophilia with inhibitors.Complete report on Hemophilia market spread across 86 pages providing 4 company profiles and 13 tables and 46 charts is now available at http://www.marketreportsonline.com/579011.html.
Treatment for hemophilia is done via replacement therapy, prophylactic therapy, on-demand therapy, gene therapy and many others. Gene therapy is being regarded as an attractive option for treatment of hemophilia. By the year 2030, the pharmaceutical companies are expected to launch their gene therapy treatment for hemophilia, and this might affect the market dynamics at large.
The growth factors of the hemophilia market include increased focus on prophylactic treatment, growing market for FVIII, increasing diagnosis rate, and increasing healthcare expenditure. Major trends of the market include development of novel hemophilia treatment, subcutaneous dosing and growing popularity of gene therapy. Further, growth prospects are hindered by high cost of therapy and consumer’s reluctance in switching to new therapy options.
The report offers an in-depth analysis of the global hemophilia market. It also covers the global as well as regional aspect of the market. The top notch players in the market exhibit a very close competition. The report profiles Pfizer Inc., Bayer Group, Shire PLC, and Novo Nordisk.
Purchase a copy of this “Global Hemophilia Market: Industry Analysis & Outlook (2017-2021)” research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=579011.
Few Points from List of Tables & Charts Provided in Global Hemophilia Market:
List of Tables
Signs & Symptoms of Hemophilia
Development of New Novel Hemophilia Treatments (2016)
Developed and Upcoming Long Acting Factor VIII Drugs
Factor IX Products in Development
Upcoming Hemophilia Gene Therapy Candidates (2016-2030)
Global Hemophilia Revenue & Market Cap Comparison by Key Players (2016)
Major Business Segments of Pfizer Inc.
Major Products Developed by Pfizer Inc. (Since November 1, 2016)
Bayer Group’s R&D Expenses by Business Segments (2016)
Shire PLC’s Major Product Approvals & Launches (2016)
Shire PLC’s Major Product Pipeline (2016)
Novo Nordisk’s Research and Development (2014-2016)
Novo Nordisk’s Product Pipeline (2016)
List of Charts
Depiction of Inheritance of Hemophilia
Types of Hemophilia
Global Hemophilia Market by Value (2012-2016)
Global Hemophilia Market Forecast by Value (2017-2021)
Global Hemophilia Market by Therapeutic Class (2016- 2030)
Global Hemophilia Traditional Factors Market Forecast by Value (2016-2021)
Global Hemophilia Market by Type (2016)
Global Hemophilia A Market Forecast by Value (2016-2021)
Global Hemophilia A Market Forecast by Therapeutic Class (2016- 2030)
Global Hemophilia A market by Severity (2016)
Global Hemophilia with Inhibitors Market Forecast by Value (2016-2021)
Other Related Report on Hemophilia Market:
Hemophilia A-Pipeline Insights, 2017: This research report provides in depth insights on the pipeline drugs and their development activities around the Hemophilia A. covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Hemophilia report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
Explore More Related Reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: MarketReportsOnline
Phone: + 1 888 391 5441
Website: http://www.marketreportsonline.com/contacts/purchase.php?name=579011
Release ID: 181244
Google
RSS